SHC — Sotera Health Company
Median target
$24
calls from the last 12 months
Implied return
+26.6%
median target vs. price
Coverage
9 analysts · 9 calls
updated in the last 12 months
Consensus
6/3/0+6 net
Buy / Hold / Sell
Which analysts are behind SHC's consensus?
See every current rating, price target and the analysts' track records for Sotera Health Company — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 9 analysts with calls on SHC updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
SHC elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-17 | Insiders | Petras Michael B. Jr.Executive Chairman | Insider sale | 850.0K sh @ $18.50 | $15.7M |
| 2026-08-17 | Insiders | Petras Michael B. Jr.Executive Chairman | Insider sale | 294.5K sh @ $18.50 | $5.4M |
| 2026-08-07 | Insiders | Rutz Michael PPresident of Sterigenics | Insider sale | 150.0K sh @ $18.84 | $2.8M |
More: insider activity · executive branch · trending